Sandoz signs on to lead launch of Pear’s digital therapeutics
A deal with Sandoz to lead the global launch of Pear’s two lead products puts marketing muscle behind the nascent class of ‘prescription digital therapeutics.’
Launch
The 2018 pipeline report: Aspiring assets to keep an eye on
The most promising products in pharma’s pipeline will compete in a landscape that increasingly rewards big risks and places an emphasis on novel mechanisms. That comes with a catch.
Five things for pharma marketers to know: Monday, November 27, 2017
Teva to cut thousands of U.S. jobs; Regeneron drops Eylea combo drug development; insurers, drugstores, and hospitals increasingly teaming up
Five things for pharma marketers to know: Thursday, November 9, 2017
GSK hires Google biotech exec to lead R&D; Merck gets FDA-approval for CMV therapy; ex-Lilly exec reportedly top HHS secretary pick
Back at Dendreon, Caggiano takes on Provenge’s comeback
Jim Caggiano had witnessed Provenge’s birth during an earlier turn at Dendreon and couldn’t understand what went wrong.
Five things for pharma marketers to know: Tuesday, May 9, 2017
Sanofi ties price increases to growth rate; Regeneron to target 7,000 docs on new eczema drug Dupixent; NIH and biotech execs meet White House officials
Five things for pharma marketers to know: Friday, January 20, 2017
Pharma among top sponsors of Trump inauguration parties; AstraZeneca exec to replace GSK president of global pharmaceuticals; EpiPen rival to relaunch
The 2017 pipeline report: What to know about next year’s launches
Here’s a look at 100 experimental therapies in late-stage clinical trials.
Five things for pharma marketers to know: Friday, October 28, 2016
Repatha and Praluent launches described by analyst as waste of money; AstraZeneca halts trial for cancer drug; health exchange choices dwindle
Reimbursement rather than Brexit more likely to impact how drugmakers order global launches
The current reimbursement climate is more likely to impact how drugmakers order their global product launches than the U.K.’s vote to exit the E.U.
